Tekmira Pharmaceuticals Corporation Roller Coaster Jumps Then DropsMark Melin
Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM), a stock ValueWalk highlighted on Thursday for its Ebola treatments, is now trading down on the day after seeing significant gains Friday and Monday.
Tekmira's stock down on on FDA's restrictions on its Ebola treatments
Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) (TSE:TKM) is down $4.80 today, trading near $19 per share, after taking off on news regarding its Ebola treatments. After closing . . .
This content is exclusively for paying members.
If you are subscribed and having an account error please clear cache and cookies if that does not work email [email protected] or click Chat.